Heparesc

human heterologous liver cells · Cytonet GmbH KG

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Heparesc, covering 2016-04-04 to 2016-04-04. Get the full timeline:

Most recent: EMA Refused: Heparesc (human heterologous liver cells) — Cytonet GmbH KG